JPRN-UMIN000002246已完成4 期
Study for Predictors of Effectiveness in Tocilizumab Therapy (PETITE) - PETITE study
Osaka City University Medical School, Center for Senile Degerative Disorders (CSDD)0 个研究点目标入组 50 人开始时间: 2009年8月1日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 16years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who received tocilizumab therapy previously Patients who received steroid newly, dose-up of steroid, plasma exchange or artificial joint replacements within 4 weeks before tocilizumab treatment
研究者
相似试验
已完成
4 期
A study for effectiveness and safety of tocilizumab therapy in rheumatoid arthritis patients with renal insufficiency.Rheumatoid arthritisJPRN-UMIN000014934HO Kumamoto Saishunsou National Hospital400
招募中
3 期
Tocilizumab in severe COVID-19COVID-19.COVID-19U07.1IRCT20150303021315N17Aryogen Pharmed85
招募中
2 期
Evaluation the Efficacy and Safety of Tocilizumab in COVID-19COVID-19 pneumonia.Confirmed diagnosis of COVID-19RA01.0IRCT20151227025726N13Shahid Beheshti University of Medical Sciences40
已完成
不适用
Clinical trial of long term efficacy for tocilizumab in systemic sclerosis and sclerodermatous chronic GVHDThe patients with systemic sclerosis or sclerodermatous chronic GVHD.JPRN-UMIN000022624Kanazawa University Hospital5
尚未招募
2 期
SMART in intermediate and high risk Oropharyngeal Squamous cell carcinomaCTRI/2021/03/031644JIPMER